- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04823286
Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform (GoodRENal)
REVID +: Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform (GoodRENal.eu)
There is wide evidence regarding the weak points of end-stage Chronic kidney disease (CKD) patients in hemodialysis, and they include three intervention aspects: exercise, nutrition and psychological support. Evidence shows that exercise for patients in hemodialysis results in increased survival rate, functional capacity, strength and health-related quality of life.
Additionally, different studies have shown the benefits of psychological interventions and the positive effect of educational programs on nutritional care for patients in hemodialysis.
Despite the well-known benefits of exercise, this kind of programs are not being implemented in the routine clinical care of hemodialysis patients.
Thus, the GoodRENal project aims to promote healthy lifestyles among dialysis patients in a holistic approach that combines exercise, nutrition and psychological wellbeing plus cognitive functioning addressing adult learners. The project will, in phase 1, explore barriers and facilitators of patients, carers and health professionals towards healthy lifestyle (physical activity, nutrition and psychological well being). In phase 2, the project will develop a health virtual platform including these three dimensions of cares. In summary, the project outputs will be:
- A didactic content in a modular platform to create an educational program for integrated treatments in patients with dialysis
- A guideline to promote healthy lifestyles among dialysis patients for health care providers
- A guideline to promote e healthy lifestyles among dialysis patients for patients and formal - nonformal carers
Study Overview
Status
Intervention / Treatment
Detailed Description
CKD stage 5D, has a high incidence, 100-200 people per million, and high prevalence, 750-1500 per million. More than 40-50% are above 65 years old, with a lower rate in women but with higher frailty than men. This cohort presents high comorbidity, malnutrition, sedentary behavior, low health-related quality of life, frailty and high dependency levels. Mortality risk is close to 15% per year. Cardiovascular disease is the main cause of death in end-stage CKD. It is also a high risk factor for peripheral artery disease and lower limbs amputation.
Supporting this cohort results in high direct and indirect costs. Additionally, these patients present high anxiety and depression rates. Comorbidity between depression and somatic illness leads to a significant increase of the illness load since there is higher symptomatology, higher morbidity, higher health costs, and worse functioning and quality of life. Current evidence suggests a bidirectional relationship between depression and medical illness. Mechanisms suggested explaining this complex relationship would include both biological and behavioral aspects. Depression is also associated with the worst adherence to treatment of comorbid patients.
There is wide evidence regarding the weak points of end-stage CKD patients in hemodialysis, and they include three intervention aspects: exercise, nutrition and psychological support. Evidence shows that exercise for patients in hemodialysis results in increased survival rate, functional capacity, strength, and health-related quality of life. Additionally, different studies have shown the benefits of psychological interventions and the positive effect of educational programs on nutritional care for patients in hemodialysis. Several combined interventions have been implemented leading to heterogeneous results.
Despite the well-known benefits of exercise, this kind of programs are not being implemented in the routine clinical care of hemodialysis patients. Patients' lack of interest regarding participation in exercise programs, time constraints, and lack of knowledge by health professionals at the hemodialysis units, are some of the factors underpinning the low implementation rate of intradialysis exercise programs.
Virtual reality (VR) refers to computer-generated interactive simulation that offers users the opportunity to participate in environments that look like objects and events of the real world.
VR exercise has been successfully implemented in neuro-rehabilitation, resulting in better balance, gait, and mobility in cerebrovascular accidents, multiple sclerosis, Guillain-Barre syndrome, and Parkinson's disease. Few studies have explored the impact of VR exercise in renal rehabilitation. Three of the partners (Universidad Cardenal Herrera-CEU, Universitat Politècnica de Valéncia, and Hospital de Manises) have implemented two randomized trials of non-immersive VR exercise intradialysis. Currently, those partners are developing a third trial with this technology and they have verified that this type of exercise has good tolerance and high adherence rates. Additionally, it has a positive impact on strength, functional capacity, physical activity level, and health-related quality of life.
Until now, the most traditional way to assess and implement psychological and psycho-educative treatments has been 'face to face'. Nevertheless, more than 50% of people suffering from depression are not being treated appropriately. This is why alternative treatment models to assess and treat are being implemented, and technology (as the internet) is an option to increase the number of patients that can be treated. Additionally, few studies have explored technology as a means to educate renal patients regarding nutrition or psychological health.
Thus, the hypothesis of the present study is that a health virtual platform designed for holistic treatment of patients undertaking hemodialysis will result in health benefits for this cohort, regarding physical activity, nutritional and psychological health. The platform will be designed according to the aims highlighted by experts, barriers, and needs of end-stage CKD patients and their caregivers. As mentioned above, end-stage chronic kidney disease patients have high comorbidity, malnutrition, sedentarism, low health-related quality of life, low physical function, frailty, and high dependency levels. So they rely on non-formal caregivers for their activities of daily living. This cohort presents high anxiety and depression levels and the combination of somatic disease plus depression results in higher symptoms, higher comorbidity, higher health resources, and worst quality of life. Besides, there is a bidirectional relationship between depression and disease, and depression is associated with lower adherence to medical treatment.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Eva SEGURA-ORTÍ, PhD
- Phone Number: 00 34 671580094
- Email: eva.segura@gmail.com
Study Locations
-
-
-
Leuven, Belgium, 3000
- Suspended
- KU Leuven
-
-
-
-
-
Thessaloníki, Greece, 57001
- Completed
- Aristotle University Of Thessaloniki
-
-
-
-
-
Valencia, Spain, 46010
- Completed
- Universitat de València
-
Valencia, Spain, 46022
- Completed
- Universitat Politècnica de València
-
-
Barcelona
-
Terrassa, Barcelona, Spain
- Recruiting
- Consorci Sanitari de Terrassa
-
Contact:
- Vicent Steve-Simo, PhD
- Email: vesteve@cst.cat
-
-
Valencia
-
Manises, Valencia, Spain, 46940
- Completed
- Hospital de Manises
-
-
-
-
-
Lund, Sweden
- Terminated
- Skane Univeristy Hospital
-
Stockholm, Sweden, 14186
- Completed
- Karolinska Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients on hemodialysis medically stable
- Ability to walk to walk at least a few steps, even if walking aids like canes or a walker ar needed
- Life expectancy greater than 6 months
Exclusion Criteria:
- Myocardial infarction in the previous 6 weeks
- Angina unstable on exercise or at rest
- Brain injury derived from a cardiovascular problem. Cerebral vascular disease such as stroke in the last 6 months or with relevant sequelae in lower limb mobility presenting hemiparesia.
- Life expectancy less than 6 months
- Cognitive impairment
- Language barriers
- Illiteracy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual reality health platform during hemodialysis
During 12 weeks subjects will use a VR platform during hemodialysis.
The intervention will be virtual reality exercise, nutritional advice and psychological wellbeing support plus cognitive training.
|
Subjects will play a virtual reality game specially adapted for subjects undertaking hemodialysis.
The game will also aim at providing nutritional advice, and improving psychological wellbeing and cognitive function.
|
No Intervention: Control group-usual care
During 12 weeks subjects will carry on with the usual care in the hemodialysis unit
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline distance walked assessed by the 6 minutes walk test at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
More meters walked in 6 minutes mean a better walking capacity
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline health-related quality of life assessed by the Short Form 36 questionnaire at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
The short form 36 gives data on 8 subscales and 2 components, higher score mean better health-related quality of life The scores range from 0 to 100, with 100 indicating optimal health and 0 reflecting very poor health.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline stance from a chair capacity assessed by the sit to stand 10 at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Time in seconds to perform 10 sit to stand repetitions.
A decrease in the time to perform the test means better functional capacity to stand up from a chair
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline usual gait speed assessed by a 4 meters gait speed test at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Speed in m/s to cover 4 meters at normal speed.
An increase in speed to perform the test means better gait speed
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline handgrip strength assessed by a handgrip dinamometer at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Bilateral handgrip strength measured in kilograms.
An increase in handgrip strength means better strength
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline lower limbs strength assessed by a dinamometer at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Bilateral lower limbs muscle strength measured in kilograms.
An increase in strength means better strength
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline physical activity level assessed by the human activity profile questionnaire, average activity score at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
The average activity score of the human activity profile questionnaire ranges from 0 to 94. .
A higher score means a higher physical activity level
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline physical activity level assessed by the international physical activity questionnaire at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
The score of the international physical activity questionnaire will be recorded in MET-minutes/week.
A higher score means a higher physical activity level
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Percentage of sessions performed from te sessions offered to measure adherence to the educational program
Time Frame: After 12 weeks of intervention
|
Calculation will be the result of sessions performed/sessions offered
|
After 12 weeks of intervention
|
Healthcare resources expenditure and costs
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Total amount in euros spent on external consultations, laboratory tests, radiology tests, hospital pharmacy, emergency department healthcare provision, and hospitalisation.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline lean body mass assessed by the bioimpedance spectroscopy at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Lean body mass is a surrogate of muscle mass in kilograms.
Increase in lean body mass means increase in muscle mass
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline qualitative assessment in food intake assessed by the Short form food questionnaire at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Qualitative assessment of food intake Short form food questionnaire.
Improvement in the dietary quality
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline nutritional status assessed by the 7 point Subjective Global Assessment at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
7 point subjective global assessment scores from 1 to 7, the higher the score the better nutritional status
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline cognitive function assessed by the Mini-mental State at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
The maximum MMSE score is 30 points.
A score of 20 to 24 suggests mild dementia, 13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline Anxiety assessed by the Hospital Anxiety and Depression Scale at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Scores obtained between 0 and 21.
The higher the score obtained, the higher the level of anxiety and depression.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline positive and negative emotions assessed by Positive and Negative Affect Schedule Scale (PANAS) at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
It includes 2 subscales (positive affect and negative affect) with 10 items each.
Each subscale can contain scores between 10 and 50.
The higher the score obtained, the greater the presence of a particular affect.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline depression assessed by the Beck Depression Inventory (BDI) at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
The scores range from 0 to 63 points.
The higher the score, the greater the severity of depressive symptoms.
Four groups are established according to the total score: 0-13, minimal depression; 14-19, mild depression; 20-28, moderate depression; and 29-63, severe depression.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline anxiety assessed by the State Trait Anxiety Inventory (STAI) at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Scale composed of 2 subscales.
The range of scores for both subscales is between 0 and 60 points so that higher scores reflect greater anxiety.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline perceived stress assessed by the Perceived Stress Scale (PSS) at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Scores obtained in a range of 0 to 56 points.
The higher the score obtained, the higher the level of perceived stress.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline cognitive state assessed by the Montreal Cognitive Assessment (MoCA)at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Scores on the MoCA assessment range from 0 to 30.
A score of 26 and above is considered normal.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline attention level assessed by the Trail Making Test (TMT) at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Scoring is based on time taken to complete the test, with lower scores being better.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Change from baseline memory assessed by the Wechsler-IV Memory Scale at 12 weeks
Time Frame: Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
The correction system allows obtaining scalar scores, indices, centiles and confidence intervals, in order to achieve a more flexible interpretation.
It is interpreted on the basis of scales.
The Spanish scales have been elaborated from a sample of almost 900 subjects aged between16 and 90 years.
|
Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Eva SEGURA-ORTÍ, Universidad CEU Cardenal Herrera, UCH CEU
Publications and helpful links
General Publications
- Segura-Orti E, Martinez-Olmos FJ. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis. Phys Ther. 2011 Aug;91(8):1244-52. doi: 10.2522/ptj.20100141. Epub 2011 Jun 30.
- Segura-Orti E, Gordon PL, Doyle JW, Johansen KL. Correlates of Physical Functioning and Performance Across the Spectrum of Kidney Function. Clin Nurs Res. 2018 Jun;27(5):579-596. doi: 10.1177/1054773816689282. Epub 2017 Jan 23.
- Segura-Orti E, Johansen KL. Exercise in end-stage renal disease. Semin Dial. 2010 Jul-Aug;23(4):422-30. doi: 10.1111/j.1525-139X.2010.00766.x.
- Segura-Orti E. [Exercise in haemodyalisis patients: a literature systematic review]. Nefrologia. 2010;30(2):236-46. doi: 10.3265/Nefrologia.pre2010.Jan.10229. Epub 2010 Jan 21. Spanish.
- Segura-Orti E, Kouidi E, Lison JF. Effect of resistance exercise during hemodialysis on physical function and quality of life: randomized controlled trial. Clin Nephrol. 2009 May;71(5):527-37. doi: 10.5414/cnp71527.
- Segura-Orti E, Rodilla-Alama V, Lison JF. [Physiotherapy during hemodialysis: results of a progressive resistance-training programme]. Nefrologia. 2008;28(1):67-72. Spanish.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-064-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
University of WashingtonJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsRecruitingChronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditionsUnited States
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
Clinical Trials on Virtual reality health platform during hemodialysis
-
Cardenal Herrera UniversityHospital de Manises; Universitat Politècnica de ValènciaCompletedEnd Stage Renal Disease | Hemodialysis-Induced SymptomSpain
-
Ruhr University of BochumCompletedPain | Anxiety | Cervical DysplasiaGermany
-
CMC Ambroise ParéRecruitingStress | Anxiety | IVFFrance
-
University of NebraskaWithdrawnVirtual Reality | VasectomyUnited States
-
The Miriam HospitalVirtually Better, Inc.UnknownObesity | OverweightUnited States
-
Fundación para la Investigación del Hospital Clínico...RecruitingAnxiety | Chronic Total OcclusionSpain
-
Rhode Island HospitalNational Institute of Mental Health (NIMH)Completed
-
Second Affiliated Hospital, School of Medicine,...RecruitingNon-suicidal Self-injuryChina
-
National Taiwan University HospitalRecruiting
-
Taipei Medical UniversityCompleted